Advertisement

Topics

ADVANCED VIRAL RESEARCH CORP Company Profile

19:51 EST 14th December 2018 | BioPortfolio

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is aggressively working to bring its flagship product, AVR118, to patients. A real blockbuster potential exists for this new type of biopolymer chemistry, which possesses novel immunomodulator activity. This peptide-nucleic acid complex, which to date has demonstrated a very favorable safety profile, appears to stimulate the pro-inflammatory response required to combat viral infections, such as HIV; and to dampen aberrant autoimmune-type inflammatory responses, which often occur in diseases such as rheumatoid arthritis. In December 2004 ADVR announced an IND approval for AVR118 by the United States Food and Drug Administration. This allows the company to conduct a Phase II clinical trial in the United States. The study will examine the safety, tolerability, and efficacy of AVR118 in patients with advanced cancer who are suffering from symptoms of progressive disease. In addition, in January 2005 the company announced the final results of its Phase I/II clinical trial of AVR118 in patients with AIDS, which was conducted in Israel at the Kaplan Medical Center. The study results showed that AVR118 continues to demonstrate evidence of unique patient benefits, a favorable safety profile, and no apparent drug-related adverse events. Advanced Viral Research Corp. has about 17,000 square feet of office, laboratory and pilot manufacturing space at its headquarters. In addition to 12 patents, ADVR currently has applications for well over 20 additional patents related to AVR118, and continues to submit applications for additional patents.

Location

200 CORPORATE BLVD. SOUTH
YONKERS
10701
United States of America

Contact

Phone: 914.376.7383
Fax: 914.376.7368
Email: staff@equityrelations.com


News Articles [1048 Associated News Articles listed on BioPortfolio]

People who don’t read the news better at predicting which articles will go viral

Figuring out how to make articles and videos go viral is the holy grail for any content creator. Although a magic formula remains elusive, in recent years, neuroscientists have forecasted which conten

Medical News Today: What is an HIV viral load?

Viral load is the amount of HIV per milliliter of blood. Antiretroviral therapy aims to reduce a person’s viral load to undetectable levels, where the virus is no longer transmittable. Here, we disc...

Veritas Pharma Signs MOU with Agrima Botanicals Corp. for a Medical Cannabis Research Collaboration

VANCOUVER, British Columbia, Sept. 30, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it ha...

Medical News Today: Undetectable viral load: Everything you need to know

A person has an undetectable viral load when there are so few viral copies of HIV in their blood that a blood test cannot detect them. This is good for a person’s overall health and means that they ...

Risk Factors for Advanced Fibrosis After SVR in Chronic HCV

This study investigated the long-term effect of achieved SVR on liver fibrosis in a cohort with pretreatment advanced chronic HCV infection. What risk factors are associated with persisting fibrosis? ...

#jobs #lifescience Paramount Recruitment: Viral Vector Engineering Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Engineering Scientist – Oxford . Ne...

Viral Protein's Role in Nipah, Hendra Viruses Identified

NewsResearchers have identified how a viral protein targets a critical function in human cells to suppress immune responses and promote fatal disease.

Medical News Today: What are the symptoms of viral pneumonia?

Viral pneumonia causes symptoms that include a cough, fever, and chills. It often occurs as a complication of the common cold. Those more at risk include young children and older adults. The condition...

PubMed Articles [2690 Associated PubMed Articles listed on BioPortfolio]

Unveiling the RNA virosphere associated with marine microorganisms.

The study of extracellular DNA viral particles in the ocean is currently one of the most advanced fields of research in viral metagenomic analysis. However, even though the intracellular viruses of ma...

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

Recent trends in click chemistry as a promising technology for virus-related research.

Click chemistry involves reactions that were originally introduced and used in organic chemistry to generate substances by joining small units together with heteroatom linkages (C-X-C). Over the last ...

What is real success in nursing research?

Who and what can define what success is in research? With the United Kingdom's seven-yearly Research Excellence Framework and recent anniversaries such as the 40 of the Journal of Advanced Nursing pro...

Evaluation of Pain in the Cognitively Impaired Patient in the Emergency Department.

The Research to Practice column is intended to improve the research critique skills of the advanced practice registered nurse and the emergency nurse, and to assist with the translation of research in...

Clinical Trials [7440 Associated Clinical Trials listed on BioPortfolio]

Third Party Anti-Viral Cytotoxic T-Cells

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infect...

Specimens From Normal Controls

The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For...

CNS Viral Dynamics and Cellular Immunity During AIDS

Understanding whether or not viral replication occurs in the brain during chronic untreated HIV-1 infection is of undeniable importance, and has implications for treatment and research pri...

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

This study will examine whether HIV-infected patients are more likely to develop resistance to antiretroviral therapy if their blood is not monitored for the number of viruses (viral load)...

FST-100 in the Treatment of Acute Viral Conjunctivitis

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to sh...

Companies [2318 Associated Companies listed on BioPortfolio]

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by re...

Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer other innovative technologies. The Company’s revolutionary diagno...

Virus Detection & Diagnostics Virinova

Our unique and proprietory diagnostic technology enables the detection and quantification of viruses without the use of PCR or antibodies - Direct detection of viruses and viral particles - F...

TanTec Biosystems, Inc.

TanTec Biosystems is a privately held biotechnology company actively engaged in the development and manufacture of sensitive and dependable biomedical standards for use in virology research and the cr...

Viral Antigens, Inc

VIRAL ANTIGENS, INC. was founded in September of 1982 to commercialize techniques for producing high quality antigens and viral components and attaching them to latex beads. Research on rubella virus ...

More Information about "ADVANCED VIRAL RESEARCH CORP" on BioPortfolio

We have published hundreds of ADVANCED VIRAL RESEARCH CORP news stories on BioPortfolio along with dozens of ADVANCED VIRAL RESEARCH CORP Clinical Trials and PubMed Articles about ADVANCED VIRAL RESEARCH CORP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ADVANCED VIRAL RESEARCH CORP Companies in our database. You can also find out about relevant ADVANCED VIRAL RESEARCH CORP Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record